Nascent Biotech Inc. Quarterly Interest Expense in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Nascent Biotech Inc. quarterly/annual Interest Expense history and growth rate from Q4 2013 to Q2 2024.
  • Nascent Biotech Inc. Interest Expense for the quarter ending June 30, 2024 was $1.95K, a 99.2% decline year-over-year.
  • Nascent Biotech Inc. Interest Expense for the twelve months ending June 30, 2024 was $149K, a 91.4% decline year-over-year.
  • Nascent Biotech Inc. annual Interest Expense for 2023 was $385K, a 75.4% decline from 2022.
  • Nascent Biotech Inc. annual Interest Expense for 2022 was $1.57M, a 3164% increase from 2021.
  • Nascent Biotech Inc. annual Interest Expense for 2021 was $48K, a 82.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $149K $1.95K -$236K -99.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $385K $22.3K -$550K -96.1% Jan 1, 2024 Mar 31, 2024 10-K 2024-07-01
Q4 2023 $935K $107 -$649K -100% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $1.58M $125K -$151K -54.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.73M $238K +$168K +240% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.57M $572K +$535K +1454% Jan 1, 2023 Mar 31, 2023 10-K 2024-07-01
Q4 2022 $1.03M $649K +$644K +12772% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 $388K $276K +$273K +10390% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $114K $70K +$66.4K +1895% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-18
Q1 2022 $48K $36.8K -$30.6K -45.4% Jan 1, 2022 Mar 31, 2022 10-K/A 2023-07-03
Q4 2021 $78.6K $5.04K -$49.9K -90.8% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $129K $2.63K -$56.1K -95.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $185K $3.51K -$84.7K -96% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $269K $67.5K -$12.9K -16.1% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-15
Q4 2020 $282K $55K +$53.1K +2764% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $229K $58.8K +$54.4K +1257% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $175K $88.2K +$88.2K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $86.6K $80.4K Jan 1, 2020 Mar 31, 2020 10-K 2021-07-08
Q4 2019 $1.92K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $4.33K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q2 2016 $311K $54.1K +$30.3K +127% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $280K $145K +$122K +537% Jan 1, 2016 Mar 31, 2016 10-K 2017-06-29
Q4 2015 $158K $75.1K +$74.3K +9359% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $83.8K $36.5K +$36.3K +21470% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $47.6K $23.8K +$23.6K +8924% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $24K $22.8K Jan 1, 2015 Mar 31, 2015 10-K 2016-07-14
Q4 2014 $794 -$3.19K -80.1% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 $169 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $264 Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q4 2013 $3.98K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.